Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.

Documenti analoghi

• A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental autoimmune encephalomyelitis.
  di: Topham, D J, et al.
  Pubblicazione: (1994)
• Stimulation of T cells by antigenic peptide complexed with isolated chains of major histocompatibility complex class II molecules.
  di: Nag, B, et al.
  Pubblicazione: (1993)
• Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.
  di: Nicolle, M W, et al.
  Pubblicazione: (1994)
• Covalent assembly of a soluble T cell receptor-peptide-major histocompatibility class I complex.
  di: Grégoire, C, et al.
  Pubblicazione: (1996)
• Self peptide requirement for class II major histocompatibility complex allorecognition.
  di: Demotz, S, et al.
  Pubblicazione: (1991)